AMRI Names BD Director

Susan Collins has been promoted to director of business development for AMRI’s North American Discovery Services, reporting to Christopher Conway, vice president, business development. She will manage AMRI’s North American discovery business development activities and professionals and spearhead efforts to expand discovery opportunities and business.

Ms. Collins has 19 years of pharmaceutical industry and leadership experience. Before joining the company in 2012, Ms. Collins held roles of increasing responsibility in sales and leadership positions at Organon BioSciences, which was later acquired by Schering-Plough and Merck. As region sales director, she was responsible for leading management and representative teams in the promotion of CNS, cardiovascular, anti-infective, anesthesia, pain management and contraceptive products across 28 states.

Thomas E. D’Ambra, Ph.D., AMRI’s president and chief executive officer, said, “AMRI’s business development professionals are integral in creating and building long-term relationships and partnerships with our many customers. AMRI’s discovery services are complex, cover our global locations and require customization of offerings and solutions for our customers’ specific needs. Susan has demonstrated an innovative and ambitious approach to building business and customer relationships since joining AMRI in 2012. We look forward to working with Susan and her team in building our North American discovery business to the next level of success.”